(Q33337184)

English

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7). (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metastatic colon cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

T André

4

0 references

author name string

F Maindrault-Goebel

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A de Gramont

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

C Louvet

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

E Carola

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Mabro

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

P Artru

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

V Gilles

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

J P Lotz

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

V Izrael

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Krulik

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Oncology Multidisciplinary Research Group (GERCOR)

12

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1000-1005

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900068-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(01)00068-5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33337184&oldid=1608044277"